Postoperative Analgesia in Patients with Hepatic Malignant Tumors
Conditions
Interventions
Control group:Epidural Bupivacaine Group
Experimental group:Liposomal Bupivacaine Paravertebral Block Group
Sponsors
Zhejiang Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age over 18 years; 2.ASA (American Society of Anesthesiologists) physical status classification of I to III; 3.Child-Pugh liver function classification of grade A or B; 4.No history of allergy to the drugs used in this study; 5.Patients scheduled for elective or scheduled open partial hepatectomy; 6.Ability to communicate effectively and willingness to participate in the study.
Exclusion criteria
Exclusion criteria: 1.Patients with contraindications to epidural or paravertebral nerve block; 2.Patients receiving therapeutic anticoagulation, chronic opioid therapy, or those with a history of substance abuse or alcohol abuse; 3.Pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Benefit of Analgesia Score over the first 3 postoperative days in both groups; | — |
Countries
China
Contacts
Public ContactMan Fang
Zhejiang Cancer Hospital
Outcome results
None listed